|
 |
MicardisThis page contains recent news articles, when available, and an overview of Micardis but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.The treatment, called Micardis® (telmisartan) Tablets 80 mg, is now approved for reduction of the risk for heart attack, stroke or death from cardiovascular ... North American Press Syndicate Cipla in talks to supply drugs to Germany's BI - Dec 15, 2009 The German company, the world's largest family-owned drugmaker, sells Micardis in 84 countries, including the US, Japan and European countries independently ... Economic Times Boehringer Ingelheim begins ovarian cancer trial - Dec 23, 2009 Meanwhile, Boehringer-Ingelheim revealed last month that Micardis (telmisartan) - its treatment for the reduction of cardiovascular morbidity risk - was ... Zenopa A roundup of 2009's FDA-approved items - Dec 29, 2009 Twynsta (amlodipine and telmisartan) tablets: This combination drug treats hypertension; it's the marriage of Norvasc with Micardis in a single pill. ... Herald & Review Un nou medicament pentru reducerea riscului de deces cardiovascular - Dec 14, 2009 La scurt timp de la aprobarea acordata de Administratia Medicamentelor si Alimentelor din SUA (FDA), telmisartan (Micardis) a primit aprobarea Comisiei ... Eva Boehringer Ingelheim: Ein Stern fällt vom Unternehmenshimmel - Dec 18, 2009 Das Gleiche droht beim Blutdrucksenker Micardis – wo ähnlich wirkende Pillen patentfrei werden. Und Spiriva – die erste Arznei gegen Raucherlunge und ... ZEIT ONLINE FDA Approves MICARDIS® (Telmisartan) As the First Treatment in its Class to ... - Oct 19, 2009 MICARDIS® is the first treatment in its class to be approved for this indication. The FDA approval is based upon clinical trial results from The ONTARGET ... Reuters CHMP Issues Positive Opinion for MICARDIS® (telmisartan) as the First ... - Oct 23, 2009 MICARDIS® (telmisartan) is set to be the ONLY treatment in its class with this indication, demonstrating proven cardiovascular (CV) protection in patients ... Reuters FDA Approves New Use for Micardis(R) in Cardiovascular Risk Reduction and ... - Oct 19, 2009 ...(1) MICARDIS is the most studied ARB in this high-risk patient population and has been commercially available to treat hypertension (high blood pressure) ... Reuters Boehringer Ingelheim Pharmaceuticals receives NDA approval from FDA for its ... - Oct 19, 2009 ...(1) MICARDIS is the most studied ARB in this high-risk patient population and has been commercially available to treat hypertension (Hypertension.aspx">high ... News-Medical.net CHMP issues positive opinion for Boehringer Ingelheim's MICARDIS - Oct 24, 2009 More specifically, CHMP's positive opinion is for the approval of Micardis for the reduction of cardiovascular morbidity in patients with manifest ... Therapeutics Daily (press release) (registration) Boehringer Ingelheim drug Micardis receives positive recommendation - Oct 26, 2009 According to the firm, Micardis could offer a much-needed alternative to ACE inhibitors in the treatment of patients with high CV risk. ... Zenopa Boehringer Ingelheim reveals FDA approval of Micardis - Oct 22, 2009 Boehringer Ingelheim has revealed that its treatment for patients at high risk of cardiovascular (CV) incidents - Micardis (telmisartan), has been approved ... Zenopa Merck-Schering deal wins EU nod; Pfizer moves 50 vet jobs to Kalamazoo; - Oct 23, 2009 Report > Boehringer Ingelheim won the backing of European drug regulators to sell the Micardis heart drug. Report > Long-acting insulin works better than ... FiercePharma Sildenafil Ratiopharm Receives Positive Criticism From The EU Panel - Nov 12, 2009 Boehringer Ingelheim International GmbH, with Micardis (telmisartan) and Bayer Schering Pharma AG (developers of Levitra), with Pritor and Kinzalmo ... I-Newswire.com (press release) * The ONTARGET Trial results reviewed by the CHMP showed that Micardis® may ... - Oct 23, 2009 If approved, Micardis® will offer a much needed alternative to ACE inhibitors in the treatment of patients with high CV risk. Earlier this week, the US Food ... PipelineReview.com (press release) First Zometa liability case reaches trial; Forest profits beat analyst estimates; - Oct 20, 2009 Report > Boehringer Ingelheim won a new indication for its Micardis drug: to reduce the risk of heart attack, stroke and CV death in patients unable to take ... FiercePharma European regulators begin Tysabri review - Oct 26, 2009 Finally, the indications of three hypertension drugs - Boehringer Ingelheim's Micardis and Bayer Schering's Pritor and Kinzalmono (all telmisartan) - are ... Pharmafocus ACE inhibitors of benefit in ischemic heart disease patients with preserved LV ... - Oct 20, 2009 In TRANSCEND, the ARB telmisartan (Micardis, Boehringer Ingelheim) did not reduce the RR for individual components of an end point, but it did reduce the RR ... TheHeart.Org Boehringer Ingelheim prize winner announced - Oct 30, 2009 This news comes after Boehringer Ingelheim received a positive opinion for the approval of Micardis (telmisartan) from the Committee for Medicinal Products ... Zenopa EU Panel: Positive Opinion On Sildenafil Ratiopharm - Oct 23, 2009 Micardis (telmisartan), from Boehringer Ingelheim International GmbH, Pritor (telmisartan), from Bayer Schering Pharma AG, and Kinzalmono (telmisartan), ... EasyBourse.com FDA批准Micardis(替米沙å?¦)用于é™?低心血管疾病å?‘作风险 - Oct 22, 2009 Boehringer Ingelheim å…¬å?¸å®£å¸ƒï¼Œç¾Žå›½é£Ÿå“?å’Œè?¯ç‰©ç®¡ç?†å±€ï¼ˆFDA）已ç»?批准了MICARDIS®（替米沙å?¦)新的适应症:é™?低心肌梗æ»ï¼Œä¸é£Žç‰å¿ƒè¡€ç®¡ç–¾ç—…引起的æ»äº¡é£Žé™©ã€‚ ... 药通天下网 InfarktusmegelÅ‘zés: új fegyver az arzenálban? - Oct 21, 2009 A Micardis a maga gyógyszerosztályában az elsÅ‘, amelyet ilyen indikációban engedélyeznek. AZ FDA döntésének alapjául az ONTARGET klinikai vizsgálat szolgált ... Weborvos 美 '미카르디스+노바스í?¬' ë³µí•©ì œ 승ì?¸ - Oct 19, 2009 ...미êµì—?ì„œ í•ê³ í˜ˆì••ì œ '미카르디스'(Micardis, telmisartan)와 '노바스í?¬'(Norvasc, amlodipine)ì?˜ ë³µí•©ì œì?¸ '트와ì?¸ìŠ¤íƒ€'(Twynsta) ì •ì œê°€ 승ì?¸ì?„ 받았다. ... 디지틀보사 혈압약 '미카르디스' 뇌졸중 ì¹˜ë£Œì œë¡œ 확대승ì?¸ - Oct 19, 2009 ...주민우 기ìž? [헬스코리아뉴스]ë² ë§?ê±°ì?¸ê²”í•˜ìž„ì œì•½ì?˜ 혈압약 '미카르디스(Micardis)'ê°€ FDA로부터 심장마비 ë°? 뇌졸중 ì¹˜ë£Œì œë¡œ 확대승ì?¸ 받았다. ... 헬스코리아뉴스 æ—¥ ì œë„¤ë¦ ì‹œìž¥ '외ìž?사 진출러시' - Nov 2, 2009 ...rabeprazole), 'ì—?비스타'(Evista, raloxifene), '미카르디스'(Micardis, telmisartan), 'ë ˆí?´ë?¼ìŠ¤íŠ¸'(Reclast, zoledronic acid)ì?˜ 만료가 ì˜ˆì •ë?¼ 있다. ... 디지틀보사 Blood pressure drug Micardis cuts heart risk: study - Mar 31, 2008 By Julie Steenhuysen. CHICAGO (Reuters) - The blood pressure drug Micardis was as effective in preventing serious heart problems in high-risk patients as ... Reuters Boehringer says hypertension drug Micardis shown to cut risk of heart... - Apr 7, 2008 INGELHEIM, Germany (Thomson Financial) - Boehringer Ingelheim GmbH. said its hypertension drug Micardis was shown in a trial to be as effective at ... Forbes Micardis HCT.(Drug overview) - Jan 22, 2007 Micardis HCT is a combination medication used in the treatment of high blood pressure. One component, telmisartan, belongs to a class of blood pressure ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com Micardis Without Prescription - Aug 11, 2007 ...the demand Micardis Without Prescription their potential new medicines typically only one will ever Micardis Without Prescription the open market, ... Sokwanele Abbott Labs amends US distribution deal for Boehringer Ingelheim drugs - Aug 2, 2005 Abbott said it will cease booking sales of Boehringer's Mobic, Flomax and Micardis treatments from 2006, when a co-promotion agreement expires. ... Forbes Boehringer's H1 operating profit falls 10 pct - Aug 7, 2008 Driving sales growth were its top medicines such as Spiriva, used to treat smoker's lung, high blood pressure drug Micardis and prostate drug Flomax. ... Reuters Boehringer Ingelheim FY sales 9.5 bln eur, up 17 pct; outpaces market... - Apr 4, 2006 Other drugs also showed strong growth, with the high blood pressure drug Micardis adding 30 pct to 720 mln eur and Sifrol to treat Parkinson's disease ... Forbes Purchase Micardis Overnight Delivery - Aug 22, 2007 ...safety and effectiveness of Purchase Micardis Overnight Delivery drugs in the US is regulated by Purchase Micardis Overnight Delivery European Union, ... Sokwanele Telmisartan (MICARDIS(R)) as Effective as Ramipril - Oct 24, 2008 New results from the landmark ONTARGET(R) Trial show that, in Asian patients at high risk of cardiovascular disease (CVD), telmisartan (MICARDIS(R)) 80mg is ... ANTARA Boehringer Ingelheim says FY net gains 15.5 pct on prescription … - Mar 27, 2007 15.5 pct to 1.722 bln eur as the company sold more prescription medicines such as respiratory treatment Spiriva and blood pressure treatment Micardis. ... Forbes Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) Is Equally … - Apr 1, 2008 The results of the landmark ONTARGET(TM) trial have demonstrated that MICARDIS(R) (telmisartan), a second-generation angiotensin II receptor blocker (ARB), ... Medical News Today - Medical News Today (press release) Potential Metabolic Effects of Micardis (Telmisartan) - Sep 13, 2005 Micardis has a beneficial effect on insulin resistance, blood sugars, and blood lipids, independent of its effect on the blood pressure. ... Diabetes In Control Nippon BI seeks new indication for Micardis. - Jul 17, 2006 Nippon BI seeks new indication for Micardis. Nippon Boehringer Ingelheim, the Japanese unit of Germany's largest drugmaker, has filed an application for an ... $9.94 - Pharma Marketletter - Alacra Store Discount Micardis Without Prescription - Sep 22, 2007 ...of medication. In the United Discount Micardis Without Prescription the main body that regulates pharmaceuticals is the Food and Drug Administration and ... Sokwanele Discount Micardis COD - Oct 30, 2007 ...only medicines (POM), which must be prescribed by a Discount Micardis COD Discount Micardis COD OTC medication is a Discount Micardis COD concern to ... Sokwanele BI's Micardis effective in patients with CKD.(Pharmaceutical industry)... - Apr 11, 2005 Results of the ESPRIT (Efficacy and Safety in Patients with Renal Impairment treated with Telmisartan) trial, published in the April 1 edition of Clinical ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Micardis Overnight - May 7, 2007 ...the United States Pharmacopoeia.In the European Pharmacopoeia. Pharmacology as Micardis Overnight chemical science is practiced by pharmacologists. ... Sokwanele Spiriva and Micardis boost Boehringer's 2007 sales 8.8%, as profit... - Apr 14, 2008 Spiriva and Micardis boost Boehringer's 2007 sales 8.8%, as profit jumps 4.8% to $2.8M. German drug major Boehringer Ingelheim has outpaced market growth ... $9.94 - Pharma Marketletter - Alacra Store Buy Micardis COD - Aug 27, 2007 Subdisciplines include clinical pharmacology (the medical field of medication Buy Micardis COD a Buy Micardis COD drug (chemical) Buy Micardis COD to cure, ... Sokwanele What's the difference between Micardis and Atenolol? - Jul 22, 2008 I can't afford the Micardis that my doctor recommends (his office is not giving out free samples anymore), but he doesn't like the Atenolol that I was on ... HealthCentral.com Continued strong growth at Boehringer Ingelheim - Aug 10, 2006 Net sales of Micardis®, a medication for reducing blood pressure that stands out for its around the clock efficacy, also increased markedly, rising by 32% ... ThePigSite.com New Data Presented on Micardis(R) (Telmisartan) Tablets in … - Jun 18, 2007 RIDGEFIELD, Conn., June 18 /PRNewswire/ -- Today, results from AMADEO*, one of a series of studies comparing two angiotensin receptor blockers (ARBs) in ... Free with registration - PR Newswire - AccessMyLibrary.com BI's Micardis shows good metabolic profile.(Boehringer Ingelheim... - Sep 12, 2005 Preclinical studies link the metabolic benefit of Boehringer Ingelheim's blood pressure lowering drug Micardis (telmisartan) to its activation of the ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones … ARB Trial Against Placebo Shows MICARDIS(R) (Telmisartan) Reduces ... - Aug 31, 2008 The results of the TRANSCEND(R)* trial demonstrate thatMICARDIS(R) 80mg (telmisartan) reduces the risk of cardiovasculardeath, myocardial infarction/heart ... Med-Kolleg Micardis improves insulin-resistant hypertension. - Aug 14, 2006 On 28 Jul 2006, Nippon Boehringer Ingelheim and Astellas Pharma Inc reported on a comparative clinical study of losartan and telmisartan. ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones Press Release: New Data Presented on Micardis(R) (Telmisartan)... - Jun 18, 2007 New Data Presented on Micardis(R) (Telmisartan) Tablets in Hypertensive Patients With Type 2 Diabetes. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Micardis shows benefits on metabolism in preclinical studies. - Sep 19, 2005 ...)n 3-7 Aug 2005, Boehringer Ingelheim published the results of a pre-clinical study which demonstrated that Micardis (telmisartan) showed beneficial effects ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones Is one possible side effect of patients taking Micardis ED .....? - Dec 24, 2008 Taking Cardizem (Diltiazem) (not for hypertention, or angina) but for rt. control as my heart is in atrial flutter has resulted in my experiencing complete ... HealthCentral.com Micardis.(Drug overview) - Jan 22, 2007 Micardis controls high blood pressure. It works by blocking the effects of a hormone called angiotensin II. Unopposed, this substance tends to constrict the ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com Micardis as good as gold standard at cutting CV risk. - Apr 7, 2008 Micardis as good as gold standard at cutting CV risk. Results of the landmark ONTARGET trial, reported at the 57th annual meeting of the American College of ... $9.94 - Pharma Marketletter - Alacra Store Boehringer Ingelheim Shrinks Its Sales Force - Sep 22, 2008 Micardis, you may recall, failed to perform well in some key clinical trials (back stories here and here). Ironically, about 400-plus InVentiv reps will be ... Pharmalot … : Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally … - Mar 31, 2008 Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular ... Pay-Per-View - PR Newswire - HighBeam Research Telmisartan Offers Better Renoprotection - Jul 1, 2007 CHICAGO—Telmisartan (Micardis HCT), a novel angiotensin receptor blocker (ARB), and the older ARB losartan have similar BP-lowering efficacy in hypertensive ... Renal and Urology News PRoFESS(R) Results Announced at XVII European Stroke Conference - May 14, 2008 The other regimen tested in PRoFESS investigated whether Micardis(R) tablets, ... Thus, the primary endpoint of superiority of MICARDIS versus placebo could ... RedOrbit Loss of vision linked to medicine - Nov 22, 2006 ..."When his numbers were this high, he was put on Micardis to try to check that ... "I have filed a report about this bad reaction to Micardis with the Food ... $2.95 - Buffalo News - NewsBank ESTUDIOS PRELIMINARES DEMUESTRAN QUE MICARDIS® ( … - Sep 7, 2005 Estocolmo, 7 de septiembre de 2005.- Los estudios preclÃnicos demuestran que Micardis (telmisartan), un antagonista de los receptores de angiotensina II, ... acceso.com HIGH BLOOD PRESSURE READINGS FOR 17 MONTHS - Aug 7, 2008 I AM TAKEN 40MG OF MICARDIS ONCE A DAY. AND I AM VERY TIRED AND SLUGGISH. SOMEONE PLEASE HELP!!!!!!!! You need a complete evaluation to look for possible ... HealthCentral.com PRoFESS Fails Across the Board in Preventing Second Strokes - May 19, 2008 ...of second strokes, nor was there a difference in that regard between telmisartan (Micardis) and placebo, researchers in the PRoFESS trial found. ... MedPage Today å‹ƒæž—æ ¼æ®·æ ¼ç¿°æŒ?ç»å¢žé•¿æ–°è‰¾æ»‹ç—…è?¯ç‰©ä¸Šå¸‚ - Sep 7, 2005 ...抗高血压è?¯ç‰©ç¾Žå?¡ç´ ®（MICARDIS®），获得了3.65亿欧元的销售é¢?，比去年增长50%多。 莫比å?¯Â® （MOBIC®），一ç§?治疗风湿性疾病的è?¯ç‰©ï¼Œå¢žé•¿åˆ°4.62亿欧元。 ... æ?œç‹? Trial Shows Two Medications Equally Effective In Reducing … - Apr 4, 2008 Results of the landmark ONTARGET Trial (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) demonstrate that MICARDIS (80 mg ... Medical News Today - Medical News Today (press release) … DEMUESTRAN QUE TELMISARTAN (Micardis®/Pritor®) ESTABILIZA EL … - Feb 22, 2005 ...- El estudio DETAIL, de 5 años de duración, ha demostrado que Telmisartán, antagonista del receptor AT1 de la angiotensina II (ARA II), frena la progresión ... acceso.com En plein essor, Boehringer Ingelheim exclut les grandes acquisitions - Apr 6, 2006 ...et de son antihypertenseur Micardis, le groupe a enregistré l'an dernier un chiffre d'affaires en hausse de 17 %, à 9,5 milliards d'euros. ... €3.00 - Les Echos MicardisPlus® in older patients with systolic hypertension, study... - May 16, 2005 Boehringer Ingelheim markets telmisartan under the trademark Micardis® in 84 ... MicardisPlus® combines two antihypertensive agents, Micardis® and a ... Medical News Today - Medical News Today (press release) MicardisPlus® in older patients with systolic hypertension, study... - May 20, 2005 Boehringer Ingelheim markets telmisartan under the trademark Micardis® in 84 ... MicardisPlus® combines two antihypertensive agents, Micardis® and a ... i-newswire.com Boehringer Drugs Disappoint in Company-Sponsored Stroke Study - Aug 28, 2008 The Micardis analysis shouldn't invalidate those findings, they wrote. ... In the first report, 8.7 percent of patients on Micardis had another stroke ... Bloomberg Micardis Plus 80mg - Hausarzt- Sprechstunde - Gesundheit und Medizin ... - Oct 8, 2007 Ich rauche nicht und ich trinke keinen Alkohol, daher verdrängt man das schnell, besonders weil ich vom Hochdruck bisher nichts spürte. ... QualiMedic Empresas.- 'Micardis' (Boehringer) reduce un 20% el riesgo infarto o... - Apr 3, 2008 ...'Micardis' (telmisartan), antihipertensivo comercializado por Boehringer Ingelheim, reduce en un 20 por ciento el número de infartos de miocardio e ictus en ... ecodiario … étude clinique canadienne démontre que le MICARDIS(R) réduit les … - Aug 31, 2008 L'étude démontre qu'une dose quotidienne de 80 mg de MICARDIS(R) ... 1,2) La thérapie avec 80 mg de MICARDIS quotidiennement a bien été tolérée et a été ... LeLézard.com Spiriva®, Micardis® y Urolosin® lideran el crecimiento de Boehringer ... - Mar 27, 2007 Ingelheim, Alemania, 27 marzo de 2007 – Boehringer Ingelheim confirma su trayectoria en 2006 con un crecimiento superior al del mercado farmacéutico mundial ... acceso.com R&D NEWS IN BRIEF -1- - Sep 19, 2005 Boehringer Ingelheim in Germany has found in preclinical studies that its angiotensin II receptor blocker (ARB) Micardis (telmisartan) showed beneficial ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones Boehringer Ingelheim anuncia los resultados de ONTARGET - Apr 2, 2008 ONTARGET demuestra que Telmisartan (MICARDIS®) es una excelente opción para los ... MICARDIS ® se convierte en una muy buena opción de tratamiento para los ... Inforo Micardis лучше защищает почки, чем Cozaar - Sep 3, 2007 18 июнÑ? компаниÑ? «Boehringer Ingelheim» на заÑ?едании ЕвропейÑ?кого общеÑ?тва гипертензии (European Society of Hypertension) в Милане (ИталиÑ?) были ... Ð?птека online Press Release: NicOx 2005 Financial Results: Strong Revenue Growth … - Mar 1, 2006 Article: Boehringer Ingelheim Receives FDA Approval for MICARDIS ... ... MICARDIS HCT Tablets are marketed in the United States by Boehringer Ingelheim ... ... Pay-Per-View - PR Newswire - HighBeam Research Nessun significativo effetto di Micardis sugli eventi cardiovascolari... - Dec 10, 2008 Mercoledì 10 Dicembre 2008 - Gli Ace inibitori riducono gli eventi cardiovascolari maggiori, ma non sono tollerati da circa il 20% dei pazienti. ... XagenaSalute Nieuw Wapen in de Strijd tegen Hart- en Vaatziekten - Apr 2, 2008 Mijlpaal studie ONTARGET(TM) toont aan dat telmisartan (Micardis(R) 80 mg) bij ... Micardis(R) 80mg biedt beide voordelen: zowel effectieve bescherming als ... Medical facts Boehringer Ingelheim sigue creciendo por encima del mercado. - Mar 30, 2007 Mientras que sus productos TOP han sido SPIRIVA®, MICARDIS® y SECOTEX® . Ingelheim, Alemania, 30 de marzo de 2007 – Boehringer Ingelheim se ha mantenido en ... Inforo PRoFESS(R) Results Announced At XVII European Stroke Conference - May 15, 2008 The other regimen tested in PRoFESS investigated whether Micardis(R) tablets, ... Thus, the primary endpoint of superiority of MICARDIS versus placebo could ... Medical News Today - Medical News Today (press release) EconomÃa/Empresas.- La farmacéutica Boehringer gana 1.800 millones … - Apr 8, 2008 ...mientras que 'Micardis' (telmisartán), para el tratamiento de la hipertensión arterial esencial, alcanzó unas ventas netas de 1.123 millones de euros, ... elEconomista.es Boehringer Ingelheim consolida su liderazgo - May 9, 2008 ...su liderazgo en diversas áreas como la EPOC con Spiriva®, la hipertensión con Micardis® y la hiperplasia benigna de próstata con Urolosin Ocas®. ... acceso.com Bayer/Boehringer: Telmisartan so wirksam wie Standardtherapie - Mar 31, 2008 ..."Telmisartan" wurde von Boehringer Ingelheim entwickelt und wird von dem Ingelheimer Unternehmen unter dem Namen "Micardis" vermarktet; die Leverkusener ... Euro am Sonntag Une étude internationale menée par le Canada démontre l'efficacité … - Apr 3, 2008 MICARDIS (dose unique de 80 mg par jour) est présentement le seul ARA éprouvé ... ONTARGET a également étudié l'intérêt de combiner MICARDIS (dose unique de ... LeLézard.com Aiming for Sales of Y100 Bil. in 2005: Mr Ohsawa of NBI - Mar 7, 2005 Among the latter four products, sales of Micardis have been rising steadily since a ban on long-term prescription was lifted. The four products accounted ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones Boehringer Ingelheim y Bayer Healthcare amplÃan el acuerdo de … - Jan 4, 2006 UU., Japón y los paÃses europeos, con las marcas comerciales Micardis® y MicardisPlus®. GlaxoSmithKline continuará promocionando Telmisartan bajo el acuerdo ... acceso.com RESEARCH & DEVELOPMENT NEWS IN BRIEF - Apr 18, 2005 The results obtained suggested that Micardis is a very effective and well-tolerated ... Micardis was administered at 40 mg or 80 mg once a day. ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones Boehringer's H1 profit down on generic competition - Jul 26, 2007 Driving sales growth were its top medicines such as Spiriva, used to treat smoker's lung, high blood pressure drug Micardis and Mirapex to treat Parkinson's ... Reuters Learn about the World Hypertension Market 2007-2023. - Feb 6, 2008 4.6 Micardis Will Become a Leading Blockbuster by the End of the Decade 4.6.1 Micardis Shows Potential Metabolic Benefits 4.6.2 Micardis Benefits from ... Free with registration - Business Wire - AccessMyLibrary.com At a glance: Bayer blitz on hypertension drug telmisartan - Jan 19, 2006 Boehringer Ingelheim continues to hold the exclusive rights to promote the drug in the UK, where it is called Micardis. The manufacturer uses Virgo Health ... PRWeek UK Doctors Testing Ways To Prevent 2nd Stroke - Sep 14, 2006 Aspirin is currently the gold standard preventive treatment, but researchers are testing three other drugs, aggrenox, plavix and micardis, to see if they ... ThePittsburghChannel.com Euro RSCG Life Chelsea: strong wins helped to offset the loss of … - Jul 1, 2008 Losses included Celgene's Thalidomid and Revlimid, which Chelsea handled for five years, and Boehringer Ingelheim's Micardis, which the agency had handled ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Article: US, Canadian patients fault Parkinson's drug. - Detroit Free... - Jun 15, 2005 Flomax(R), Mirapex(R) and Micardis ... country manager for Boehringer Ingelheim Brazil and the business ... PR Newswire. Article: Boehringer Ingelheim GmbH ... Pay-Per-View - Detroit Free Press - HighBeam Research Bayer buys hypertension drug rights from GSK - Jan 12, 2006 Boehringer Ingelheim discovered telmisartan, and markets it in 84 countries globally under the brand name Micardis (and as Micardis Plus in combination with ... Pharmafocus Bedre blodtrykksbehandling - Apr 16, 2008 Resultatene fra den nye studien viser at AII-blokkeren Micardis beskytter like godt mot ... Studien bekrefter ogsÃ¥ at Micardis gir færre bivirkninger, ... Lommelegen.no DRUG PLAN DOESN'T SEEM TO BE SAVING - Oct 15, 2005 Micardis$53.63. Synthroid$28. I recently paid, with a 5 percent discount, ... Micardis$53.63. Synthroid$18.36. The result is, that with Mr. Bush's Medicare ... Pay-Per-View - South Florida Sun - Sentinel - ProQuest Archiver Press Release: TRANSCEND(TM) Trial Results Presented at European … - Aug 31, 2008 Landmark ARB trial investigated Micardis(R) (telmisartan) against placebo in ... Article: Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally . ... Pay-Per-View - PR Newswire - HighBeam Research RzÄ…d zapowiada kolejne duże zmiany w zasadach refundacji leków - Jan 13, 2006 StaniaÅ‚ za to obniżajÄ…cy poziom cholesterolu Micardis (z 77,5 do 55,88 zÅ‚) oraz Xartan. Tzw. Sartany, które można byÅ‚o kupić za 100-procentowÄ… odpÅ‚atnoÅ›ciÄ…, ... NaszeMiasto.pl Rigney v. Marcum, No. 06-187-REW (EDKy. 10/11/2007) - Oct 11, 2007 Rigney's high blood pressure medication included Atenolol, Micardis, and HCTZ. See id. at 26; ... The unlabeled medication included Micardis and Vioxx. ... $2.95 - U.S. District Court, Eastern District... - VersusLaw Euro RSCG life: overcame a year of challenges and uncertainty with … - Jul 1, 2006 Other Euro RSCG Life Chelsea accounts include: Wyeth's ... treatments Micardis and Micardis HCT. Euro RSCG Life Chelsea underwent top-level management ... ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Medications may cause chronic pain - Dec 11, 2007 I am taking Micardis, Caduet, Toprol and Flomax. I am taking all of these medications and still have no relief. Your opinion would be greatly appreciated. ... $2.95 - Erie Times-News - NewsBank New Powerful Antihypertensive MicardisPlus(R) 80/25 (80mg telmisartan/... - Apr 14, 2008 Under the trademarks MICARDIS(R) and MICARDISPLUS(R) (combination with hydrochlorothiazide) the company markets telmisartan in 84 countries around the world ... ots.at The Top 50: Euro RSCG Life Chelsea - Jul 1, 2007 Wyeth's Pristiq to treat depression and vasomotor symptoms; and Boehringer Ingelheim's blood pressure treatments Micardis and Micardis HCT. ... Medical Marketing & Media - Medical Marketing and Media Boehringer Ingelheim Drugs Have No Stroke Advantage - Sep 3, 2008 Two Boehringer Ingelheim drugs, Micardis and Aggrenox, ... Patients who started taking Micardis (telmisartan) soon after an ischemic stroke and continued on ... FDA news - FDA news (subscription) Interview with Dr. Paul Bonnabel, chairman and CEO of Boehringer … - Jun 13, 2007 Our second drug, which is selling very well also is Micardis (telmisartan), ... For Micardis, we are also seeing a steady stream of clinical results. ... Free with registration - China Business News - AccessMyLibrary.com Key business with prescription medicines continues to boost growth at... - Jul 30, 2007 Key global products, such as Spiriva®, Micardis®, Mirapex®/Sifrol® performed ... The leading cardiovascular product, Micardis®, a drug for the treatment of ... webwire.com Press Release: Largest-Ever Secondary Stroke Prevention Trial … - Oct 26, 2006 The study will also examine whether Boehringer Ingelheim's telmisartan (Micardis(R)), an angiotensin receptor blocker (ARB), in addition to the usual care ... Pay-Per-View - PR Newswire - HighBeam Research Zobacz, ile zapÅ‚acisz za leki refundowane - Oct 14, 2005 Stanieje za to obniżajÄ…cy poziom cholesterolu Micardis (z 77,5 do 55,88 zÅ‚) oraz Xartan. Tzw. Sartany, które można byÅ‚o kupić za 100-procentowÄ… odpÅ‚atnoÅ›ciÄ… ... NaszeMiasto.pl “风æµ?â€?抗高血压è?¯â€œæ›¿ç±³æ²™å?¦â€?内外交困 - Jul 22, 2005 ...替米沙å?¦æœ€å…ˆç”±å¾·å›½å‹ƒæž—æ ¼æ®·æ ¼ç¿°å…¬å?¸é¦–å…ˆç ”åˆ¶ï¼Œå¹¶äºŽ1999年在美国首次上市，商å“? å??Micardis（美å?¡ç´ ），是一ç§?æ¯?æ—¥1次å?£æœ?用于治疗原å?‘性高血压的è?¯ç‰©ã€‚ ... æ?œç‹? Sanofi-Aventis.(Update) | Article from Medical Marketing & Media | … - Dec 1, 2006 Other Euro RSCG Life Chelsea accounts include: Wyeth's ... treatments Micardis and Micardis HCT. Euro RSCG Life Chelsea underwent top-level management ... ... Pay-Per-View - Medical Marketing & Media - HighBeam Research AbelsonTaylor.(AGENCIES)(appointments)(Brief article) | Article from ... - Nov 1, 2008 Other Euro RSCG Life Chelsea accounts include: Wyeth's ... treatments Micardis and Micardis HCT. Euro RSCG Life Chelsea underwent top-level management ... ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Pantello, Sweeney, Wood to enter Hall.(NEWS) | Article from Medical … - Dec 1, 2008 Other Euro RSCG Life Chelsea accounts include: Wyeth's ... treatments Micardis and Micardis HCT. Euro RSCG Life Chelsea underwent top-level management ... ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Schering-Plough and GlaxoSmithKline have awarded the consumer … - Nov 1, 2008 Other Euro RSCG Life Chelsea accounts include: Wyeth's gastroesophageal ... treatments Micardis and Micardis HCT. Euro RSCG Life Chelsea underwent top-level ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Euro RSCG Life.(AGENCIES) | Article from Medical Marketing & Media | ... - Jan 1, 2008 Other Euro RSCG Life Chelsea accounts include: Wyeth's ... treatments Micardis and Micardis HCT. Euro RSCG Life Chelsea underwent top-level management ... ... Pay-Per-View - Medical Marketing & Media - HighBeam Research JAPAN'S ASTELLAS PHARMA TO INCREASE NUMBER OF PRIORITY … - Nov 10, 2005 Lipitor and Micardis are products of the former Yamanouchi Pharmaceutical Co., while Luvox and Myslee are products of the former Fujisawa Pharmaceutical Co. ... $4.95 - AsiaPulse News - ECNext Euro RSCG Life names Metropoulos CEO.(NEWS)(appointment of Jim … - Dec 1, 2006 Other Euro RSCG Life Chelsea accounts include: Wyeth's ... treatments Micardis and Micardis HCT. Euro RSCG Life Chelsea underwent top-level management ... ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Best product launch advertisement in consumer press.(Creative) |... - Nov 1, 2006 Other Euro RSCG Life Chelsea accounts include: Wyeth ... treatments Micardis and Micardis HCT. Euro RSCG Life Chelsea underwent top-level management ... ... Pay-Per-View - Medical Marketing & Media - HighBeam Research At work with ...(PEOPLE)(Interview)(Brief article) | Article from... - Feb 1, 2007 Other Euro RSCG Life Chelsea accounts include: Wyeth's ... treatments Micardis and Micardis HCT. Euro RSCG Life Chelsea underwent top-level management ... ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Upward move.(PEOPLE)(promotion of Donna Murphy)(Brief article) | … - Feb 1, 2008 Other Euro RSCG Life Chelsea accounts include: Wyeth ... treatments Micardis and Micardis HCT. Euro RSCG Life Chelsea underwent top-level management ... ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Former Euro PR head joins GolinHarris.(PUBLIC RELATIONS) | Article … - Jul 1, 2007 Other Euro RSCG Life Chelsea accounts include: Wyeth's ... treatments Micardis and Micardis HCT. Euro RSCG Life Chelsea underwent top-level management ... ... Pay-Per-View - Medical Marketing & Media - HighBeam Research May's winner ...(NAME THAT BRAND) | Article from Medical Marketing & ... - Aug 1, 2005 Other Euro RSCG Life Chelsea accounts include: Wyeth's ... treatments Micardis and Micardis HCT. Euro RSCG Life Chelsea underwent top-level management ... ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Euro RSCG Life MetaMax: reorganized pod structure helps management … - Jul 1, 2008 Other Euro RSCG Life Chelsea accounts include: Wyeth's ... treatments Micardis and Micardis HCT. Euro RSCG Life Chelsea underwent top-level management ... ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Euro RSCG Life MetaMax: winning pitches with its new, flat management... - Jul 1, 2007 Other Euro RSCG Life Chelsea accounts include: Wyeth's ... treatments Micardis and Micardis HCT. Euro RSCG Life Chelsea underwent top-level management ... ... Pay-Per-View - Medical Marketing & Media - HighBeam Research |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |